Tumor-infiltrating lymphocytes (TIL) therapy
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for Tumor-infiltrating lymphocytes (TIL) therapy, covering 2016-06-27 to 2026-01-21. Get the full timeline:
Most recent: Clinical Trial Update: TIL for Patients With Advanced Solid Tumor [Phase 1]